Selected article for: "active infection and lyme disease"
Author: Schutzer, Steven E; Body, Barbara A; Boyle, Jeff; Branson, Bernard M; Dattwyler, Raymond J; Fikrig, Erol; Gerald, Noel J; Gomes-Solecki, Maria; Kintrup, Martin; Ledizet, Michel; Levin, Andrew E; Lewinski, Michael; Liotta, Lance A; Marques, Adriana; Mead, Paul S; Mongodin, Emmanuel F; Pillai, Segaran; Rao, Prasad; Robinson, William H; Roth, Kristian M; Schriefer, Martin E; Slezak, Thomas; Snyder, Jessica L; Steere, Allen C; Witkowski, Jan; Wong, Susan J; Branda, John A
Title: Direct Diagnostic Tests for Lyme Disease
  • Cord-id: 4ikzvnmv
  • Document date: 2018_10_11
    • ID: 4ikzvnmv
    Snippet: Borrelia burgdorferi was discovered to be the cause of Lyme disease in 1983, leading to seroassays. The 1994 serodiagnostic testing guidelines predated a full understanding of key B. burgdorferi antigens and have a number of shortcomings. These serologic tests cannot distinguish active infection, past infection, or reinfection. Reliable direct-detection methods for active B. burgdorferi infection have been lacking in the past but are needed and appear achievable. New approaches have effectively
    Document: Borrelia burgdorferi was discovered to be the cause of Lyme disease in 1983, leading to seroassays. The 1994 serodiagnostic testing guidelines predated a full understanding of key B. burgdorferi antigens and have a number of shortcomings. These serologic tests cannot distinguish active infection, past infection, or reinfection. Reliable direct-detection methods for active B. burgdorferi infection have been lacking in the past but are needed and appear achievable. New approaches have effectively been applied to other emerging infections and show promise in direct detection of B. burgdorferi infections.

    Search related documents:
    Co phrase search for related documents
    • abundant protein and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • abundant protein and low abundance: 1, 2, 3
    • abundant protein and low sensitivity: 1
    • accessory genome and accurate diagnostic: 1
    • accessory genome and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12